NCT02564692
GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
Enrolling by Invitation
Not specifiedAges 50–90ObservationalBanner HealthInvestigator-initiated
~500,000 participants
Updated 2025-12-09 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of individuals who enroll in GeneMatch
Measured over 15 years
Conditions
Where it's being run
1 sites across 1 statesArizona1
Study leadership
- Jessica B Langbaum, PhD · PRINCIPAL_INVESTIGATOR · Banner Alzheimer's Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 50-90, inclusive
Provide basic demographic, medical history, and contact information
Consent to APOE genotyping without receiving results
Live in the United States
Exclusion
Unable to comply with this project's protocol requirements
Self-reported diagnosis of dementia or any other objective cognitive impairment syndrome
What this trial measures
- Number of individuals who enroll in GeneMatch15 years